Market closedADR
Smith & Nephew/$SNN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Smith & Nephew
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Ticker
$SNN
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
17,349
Website
Smith & Nephew Metrics
BasicAdvanced
$11B
55.43
$0.47
0.72
$0.73
3.43%
Price and volume
Market cap
$11B
Beta
0.72
52-week high
$31.53
52-week low
$23.65
Average daily volume
990K
Dividend rate
$0.73
Financial strength
Current ratio
2.888
Quick ratio
1.215
Long term debt to equity
61.88
Total debt to equity
63.077
Dividend payout ratio (TTM)
79.37%
Interest coverage (TTM)
6.11%
Management effectiveness
Return on assets (TTM)
5.44%
Return on equity (TTM)
7.86%
Valuation
Price to earnings (TTM)
55.426
Price to revenue (TTM)
3.914
Price to book
1.65
Price to tangible book (TTM)
7.18
Price to free cash flow (TTM)
37.522
Dividend yield (TTM)
2.78%
Forward dividend yield
3.43%
Growth
Revenue change (TTM)
4.70%
Earnings per share change (TTM)
56.15%
3-year revenue growth (CAGR)
3.69%
3-year earnings per share growth (CAGR)
-7.66%
What the Analysts think about Smith & Nephew
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Smith & Nephew stock.
Smith & Nephew Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Smith & Nephew Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Smith & Nephew News
AllArticlesVideos
Smith & Nephew falls after downgrade by leading investment bank
Proactive Investors·1 month ago
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025
GlobeNewsWire·1 month ago
Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closedADR
Upcoming events
May28
Smith & Nephew
Dividend·Payment
$0.462
Per share
FAQs
What’s the current market cap for Smith & Nephew stock?
Smith & Nephew (SNN) has a market cap of $11B as of April 16, 2025.
What is the P/E ratio for Smith & Nephew stock?
The price to earnings (P/E) ratio for Smith & Nephew (SNN) stock is 55.43 as of April 16, 2025.
Does Smith & Nephew stock pay dividends?
Yes, the Smith & Nephew (SNN) stock pays dividends to shareholders. As of April 16, 2025, the dividend rate is $0.725 and the yield is 3.43%. Smith & Nephew has a payout ratio of 79.37% on a trailing twelve-month basis.
When is the next Smith & Nephew dividend payment date?
The next Smith & Nephew (SNN) dividend payment is scheduled for May 28, 2025.
What is the beta indicator for Smith & Nephew?
Smith & Nephew (SNN) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.